Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol

Beta-adrenoblockers, included in any cardiovascular disease treatment standard, became a key part of clinical practice only in late XX century. Nebivolol is a highly selective beta-1 -adrenoiblocker, modulating endothelial NO release and subsequent physiological vasodilatation. Nebivolol has multipl...

Full description

Bibliographic Details
Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	V. I. Makolkin, D. A. Napalkov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Subjects:	β-adrenoblockers nebivolol coronary heart disease arterial hypertension heart failure
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1799

Similar Items

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01)

Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
by: M. G. Bubnova
Published: (2008-12-01)

REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA
by: V. I. Makolkin
Published: (2016-01-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers
by: L. L. Kirichenko, et al.
Published: (2006-12-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines
by: V. I. Makolkin
Published: (2010-12-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction
by: Kyungil Park, et al.
Published: (2023-09-01)

Modern management of arterial hypertension: has the position of beta-adrenoblockers changed
by: S. Yu. Martsevich
Published: (2007-08-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina
by: Zumreta Kušljugić, et al.
Published: (2005-02-01)

Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers
by: I. P. Rubesh, et al.
Published: (2008-08-01)

EFFICACY OF NEBIVOLOL IN TREATMENT OF WOMEN WITH CORONARY HEART DISEASE
by: N. A. Koryagina, et al.
Published: (2014-12-01)

NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)

Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome
by: I. N. Medvedev
Published: (2006-06-01)

Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction
by: Rasim Kutlu, et al.
Published: (2013-06-01)

Nitric oxide mediated effects of nebivolol on erectile function in rats with heart failure
by: Guldem Mercanoglu, et al.
Published: (2021-07-01)

BETA-ADRENOBLOCKERS IN LONG-TERM MONOTHERAPY AMONG PATIENTS WITH ARTERIAL HYPERTENSION: EFFECTS ON QUALITY OF LIFE AND TREATMENT COMPLIANCE
by: F. Z. Kasumova
Published: (2010-10-01)

NOVEL COMBINATION OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR PERINDOPRIL AND HIGHLY SELECTIVE β-ADRENOBLOCKER BISOPROLOL: PRIME AMONG THE EQUAL
by: O. D. Ostroumova, et al.
Published: (2018-06-01)

Use of alpha-adrenoblockers intherapy of benign prostatic hyperplasia in patients with arterial hypertension
by: E В Mazo, et al.
Published: (2004-03-01)